Navigation Links
BioVigil Releases Second-Generation Hand Hygiene Monitoring System
Date:3/16/2010

SANTA ROSA, Calif., March 16 /PRNewswire/ -- BioVigil LLC has released the second generation of the BioVigil hand hygiene monitoring system. The innovative system enables hospitals to more effectively combat Hospital-Acquired Infections (HAIs) by dramatically increasing hand hygiene compliance among healthcare workers.  

HAIs waste over $20-30 billion each year, with as many as one in ten hospital patients picking up a secondary infection while spending time in a hospital. Infections are particularly dangerous for patients recovering from surgery, with as many as 99,000 deaths per year in the United States alone attributed to HAIs.

According to the U.S. Centers for Disease Control (CDC), hand hygiene is the single most effective way to combat hospital-acquired infections. As a result, 34 states have implemented standards which require hospitals to improve on hand hygiene.

The second-generation BioVigil system incorporates innovative badge technology and related sensors to effectively monitor hand hygiene compliance in hospitals. The system verifies the use of hand sanitizer in every patient's room, and records compliance data in a secure database.

"Our second-generation system solves the accuracy problems that are inherent in RF-based sensors," explains Brian Sheahan, Chief Executive Officer for BioVigil LLC. "An RF-based system does not have the accuracy and sensitivity which our system offers. We know with 100% accuracy when a healthcare worker enters and exits a location. Our system is simple, cost-effective and saves lives.

"In addition, the BioVigil system uses an alcohol sensor on the ID badge of the healthcare worker, so that a nurse or doctor can simply enter a patient's room, then use hand sanitizer while approaching the patient's bed and interacting with the patient. We have been able to design a sensor network which makes the system highly user-friendly and patient-friendly. The bright green and red LEDs embedded in the ID badge enable other healthcare personnel and even patients to easily see whether a healthcare worker is in compliance."

Mr. Sheahan noted that BioVigil completed an IRB-approved trial with VCU Medical Center during September 2009, validating the successful operation of its second-generation BV-140 technology. Dr. Michael Edmond of VCU Medical Center will be presenting results of the trial at the Society for Healthcare Epidemiology of America (SHEA) conference in Atlanta, GA on Sunday, March 21, 2010 at 11:45 a.m.

BioVigil (http://www.biovigil.org), based in Santa Rosa, California, has a number of patents which protect its proprietary approach at hand hygiene detection and reporting. The company has refined its unique approach to hand hygiene compliance over four years of development activity and repeated trials.    

    
    
    Contact: 
    
    Joe Madden
    BioVigil
    (707) 508-9170
    biovigil@comcast.net 

This release was issued through eReleases(TM).  For more information, visit http://www.ereleases.com.

SOURCE BioVigil LLC

Back to top

RELATED LINKS
http://www.biovigil.org

'/>"/>

SOURCE BioVigil LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Robert B. Arnot Releases White Paper on the Silent Threat of H1N1 and Other Infectious Diseases
2. Providence Service Corporation Releases Fourth Quarter and Year End 2009 Results
3. GeneGo Releases Content and Tools From Industry-FDA Driven MetaTox Partnership Via ToxHunter(TM)
4. Pi2 Solutions Releases the Latest Version of its Product Literature Database System for the Biopharmaceutical Industry
5. CEL-SCI Corporation Releases Letter to Shareholders
6. Berkery Noyes Releases 2009 Pharma and Healthcare Information Merger & Acquisition Trends
7. SpectraScience Releases Shareholder Newsletter
8. Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics
9. Lilly Releases Latest Value of Medicine Resource Guide About Key Issues Facing the Pharmaceutical Industry
10. ECRI Institute Releases Roadmap to the Evidence on Finasteride for Prevention of Prostate Cancer: New Hotline Report to Aid Healthcare Decision Makers and Journalists
11. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)...  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" ... on tissue protection, repair and regeneration, today announced ... received a positive response from the U.S. FDA ... RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 is ... beta 4 ("Tß4") as the active pharmaceutical ingredient. ...
(Date:2/27/2017)...  CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) ... Ph.D., as President and Chief Executive Officer (CEO) and member ... Craig succeeds Richard Love , interim President and CEO ... Directors.  Dr. Craig has over 20 years of experience in ... Europe . "On behalf of ...
(Date:2/24/2017)... Following receiving CE Marking in Europe ... AMAR is a major milestone for the country where the device was developed ... market in Israel   ... inclusion in the National Health Basket , Israel , ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced wound ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency based in ... Palo Alto, is proud to announce an important upgrade to its geographic information pages, ... care close to home, and by having city-specific pages, NuevaCare is answering that information ...
(Date:2/26/2017)... PA (PRWEB) , ... February 26, 2017 , ... ... and services with Pay-For-Performance B2B Marketing. B2B Sellers will now only pay for B.A.N.T. ... Robert Hennessey, the founder of IndustryArchive.Org, said, “Given the new reality that B2B buyers ...
(Date:2/26/2017)... ... ... ODH, Inc.™ announced today it will exhibit and speak at the 10th ... Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present on how ... management. , ODH will also have an exhibit booth where attendees may speak to ...
(Date:2/26/2017)... ... 26, 2017 , ... Occupational pesticide exposure is linked to ... mutation, according to a study released today at the 1st Pan American Parkinson’s ... between pesticides and incidence of sporadic PD through occupational exposure. This latest study, ...
(Date:2/24/2017)... Lake MN (PRWEB) , ... February 24, 2017 ... ... launch of its newly designed TaskMate Go. Core benefits and advantages built into ... finish and a stylish, functional look and feel. Ability to gain the benefits ...
Breaking Medicine News(10 mins):